NYSE · Medical - Equipment & Services

Hims & Hers Health, Inc. (HIMS) Stock

$28.06 -5.01% NYSE: HIMS Healthcare

Valuation

MetricValue
Price$28.06
Market Cap$6.26B
P/E Ratio-47.54
P/B Ratio20.74
P/S Ratio2.51
EPS (TTM)$0.51
52-Week High$65.30
52-Week Low$13.74
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-30.03%
ROA-3.91%
ROCE-4.32%
Gross Margin4.51%
Operating Margin4.51%
Net Margin-5.51%
Debt/Equity4.77
Current Ratio1.90

Annual Financials (USD)

Metric20212022202320242025
Revenue$272.0M$527.0M$872.0M$1.5B$2.3B
Operating Profit$-115.0M$-69.0M$-29.0M$62.0M$106.0M
Net Profit$-108.0M$-66.0M$-24.0M$126.0M$128.0M
EPS$-0.58$-0.32$-0.11$0.53$0.51
Op Margin-42.3%-13.0%-3.4%4.2%4.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$421.0M$366.0M$441.0M$708.0M$2.2B
Total Liabilities$86.0M$55.0M$97.0M$231.0M$1.6B
Cash$72.0M$47.0M$97.0M$221.0M$229.0M
Borrowings$5.0M$5.0M$10.0M$11.0M$1.1B

Latest News

1 Cash-Producing Stock to Target This Week and 2 Facing Headwinds StockStory · Jul 22, 2026 HIMS Stock Snaps 3-Day Losing Streak: FDA Adds 8 New Peptide Voters Deemed ‘More Qualified And Less Conflicted’ Stocktwits · Jul 22, 2026 HIMS: Lowering target price to $34.00 Argus Research · Jul 22, 2026 HIMS Stock On A 3-Day Slide: CFO Cashes Out $229K In Shares Ahead Of FDA Peptide Meeting Stocktwits · Jul 21, 2026 Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company Business Wire · Jul 17, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-34.0M$-27.0M$73.0M$251.0M$300.0M
Investing Cash Flow$-161.0M$27.0M$-39.0M$-72.0M$-1.3B
Financing Cash Flow$-39.0M$-33.0M$-11.0M$-108.0M$-207.0M
Net Cash Flow$44.0M$-25.0M$50.0M$124.0M$8.0M
Free Cash Flow$-39.0M$-34.0M$47.0M$198.0M$74.0M

Valuation & Return Ratios

MetricValue
PEG Ratio1.13
EV / EBITDA-96.91
FCF Yield1.39%
Quick Ratio0.87
Interest Coverage0.00
Return 1Y-42.40%
Return 3Y302.18%
Return 5Y249.33%

Ownership

Insiders Held5.51%
Institutions Held70.35%
Institutions Float Held74.45%
Institutional HolderSharesReport Date
Blackrock Inc.26,337,1582026-03-31
Vanguard Portfolio Management LLC10,183,8132026-03-31
Vanguard Capital Management LLC9,339,7112026-03-31
Morgan Stanley8,889,0882026-03-31
State Street Corporation7,460,0232026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
CABRCaring Brands, Inc. $1.16 -4.92% -1.64 $10.55M 0.00%
COTYCoty Inc. $2.81 +0.72% -3.82 $2.47B 0.00%
ELEstee Lauder Companies, Inc. (The) $97.07 +2.92% 185.24 $35.11B 1.48%
ELFe.l.f. Beauty, Inc. $107.55 +1.50% 104.54 $6.34B 0.00%
EPCEdgewell Personal Care Company $27.73 +0.87% -13.48 $1.28B 2.22%

About Hims & Hers Health, Inc.

Hims & Hers Health, Inc. is led by CEO Andrew Dudum, employs 2,442 people, headquartered in San Francisco, US, publicly traded since 2019.

Hims & Hers Health, Inc. (HIMS) stock trades at $28.06 with a market capitalization of $6.26B. The stock is valued at a price-to-earnings (P/E) ratio of -47.54, price-to-book of 20.74, price-to-sales of 2.51. Over the past 52 weeks the stock has ranged between $13.74 and $65.30, and currently trades 57.0% below its 52-week high.

On profitability, Hims & Hers Health, Inc. generates a return on equity (ROE) of -30.03%, return on capital employed of -4.32%, an operating margin of 4.51%, a net profit margin of -5.51%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1167.49 -0.18% JNJ Johnson & Johnson $257.43 +0.37% ABBV AbbVie Inc. $274.33 +0.70% MRK Merck & Company, Inc. Common Stock (new) $143.09 +0.50% UNH UnitedHealth Group Incorporated Common Stock (DE) $383.12 +3.28% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $656.23 +0.65% AMGN Amgen Inc. $406.05 -0.34% GILD Gilead Sciences, Inc. $147.20 +0.07% ABT Abbott Laboratories $100.17 +1.71% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides